BPM31510IV, a highly bioavailable intravenously administered coenzyme Q10 (CoQ10) formulation, was evaluated in a phase Ia/Ib study as monotherapy and in combination with chemotherapy in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback